{"transactions":[{"id":2785923,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-16T22:37:24.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":7102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014."}],"balance_after":0,"derivative":{"exercise_price":16.62,"expiration_date":"2021-03-31","underlying":"Common Stock","underlying_shares":7102},"source":{"system":"sec-edgar","filing":"0001209191-21-021080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121021080/doc4.xml","form_type":"4"}},{"id":2785922,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Common Stock","published_at":"2021-03-16T22:37:24.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":3052,"price":52.2137,"value":159356.2124,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 3,052 shares sold in the price range of $52.11 to $52.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37327,"source":{"system":"sec-edgar","filing":"0001209191-21-021080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121021080/doc4.xml","form_type":"4"}},{"id":2785921,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Common Stock","published_at":"2021-03-16T22:37:24.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":4050,"price":51.7759,"value":209692.395,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 4,050 shares sold in the price range of $51.10 to $52.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":40379,"source":{"system":"sec-edgar","filing":"0001209191-21-021080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121021080/doc4.xml","form_type":"4"}},{"id":2785920,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Common Stock","published_at":"2021-03-16T22:37:24.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":7102,"price":16.62,"value":118035.24,"ownership":{"direct":true},"balance_after":44429,"source":{"system":"sec-edgar","filing":"0001209191-21-021080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121021080/doc4.xml","form_type":"4"}},{"id":2812483,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T22:57:33.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":3763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Inogen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on\nthe 1st day of the month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on\nthe 1st day of the month."}],"balance_after":3763,"derivative":{"underlying":"Common Stock","underlying_shares":3763},"source":{"system":"sec-edgar","filing":"0001209191-21-017158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121017158/doc4.xml","form_type":"4"}},{"id":2812482,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T22:57:33.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":1092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Inogen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month."}],"balance_after":3276,"derivative":{"underlying":"Common Stock","underlying_shares":1092},"source":{"system":"sec-edgar","filing":"0001209191-21-017158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121017158/doc4.xml","form_type":"4"}},{"id":2812481,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Common Stock","published_at":"2021-03-03T22:57:33.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":874,"price":53.14,"value":46444.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2021."}],"balance_after":37327,"source":{"system":"sec-edgar","filing":"0001209191-21-017158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121017158/doc4.xml","form_type":"4"}},{"id":2812480,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Common Stock","published_at":"2021-03-03T22:57:33.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":1092,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38201,"source":{"system":"sec-edgar","filing":"0001209191-21-017158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121017158/doc4.xml","form_type":"4"}},{"id":2960413,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Common Stock","published_at":"2020-12-03T00:10:22.000Z","date":"2020-12-01","kind":"tax_withholding","acquired":false,"shares":76,"price":35.28,"value":2681.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020."}],"balance_after":37109,"source":{"system":"sec-edgar","filing":"0001209191-20-061305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120061305/doc4.xml","form_type":"4"}},{"id":2960412,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Common Stock","published_at":"2020-12-03T00:10:22.000Z","date":"2020-12-01","kind":"tax_withholding","acquired":false,"shares":66,"price":35.28,"value":2328.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020."}],"balance_after":37185,"source":{"system":"sec-edgar","filing":"0001209191-20-061305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120061305/doc4.xml","form_type":"4"}},{"id":2960411,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Marketing"}}],"security":"Common Stock","published_at":"2020-12-03T00:10:22.000Z","date":"2020-12-01","kind":"tax_withholding","acquired":false,"shares":107,"price":35.28,"value":3774.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020."}],"balance_after":37251,"source":{"system":"sec-edgar","filing":"0001209191-20-061305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120061305/doc4.xml","form_type":"4"}},{"id":3040902,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-09-02T23:11:46.000Z","date":"2020-09-01","kind":"tax_withholding","acquired":false,"shares":76,"price":28.94,"value":2199.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020."}],"balance_after":37358,"source":{"system":"sec-edgar","filing":"0001209191-20-049261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120049261/doc4.xml","form_type":"4"}},{"id":3040901,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-09-02T23:11:46.000Z","date":"2020-09-01","kind":"tax_withholding","acquired":false,"shares":66,"price":28.94,"value":1910.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020."}],"balance_after":37434,"source":{"system":"sec-edgar","filing":"0001209191-20-049261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120049261/doc4.xml","form_type":"4"}},{"id":3040900,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-09-02T23:11:46.000Z","date":"2020-09-01","kind":"tax_withholding","acquired":false,"shares":106,"price":28.94,"value":3067.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001209191-20-049261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120049261/doc4.xml","form_type":"4"}},{"id":3123676,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-06-03T22:26:25.000Z","date":"2020-06-01","kind":"tax_withholding","acquired":false,"shares":75,"price":38.55,"value":2891.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020."}],"balance_after":37606,"source":{"system":"sec-edgar","filing":"0001209191-20-034205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120034205/doc4.xml","form_type":"4"}},{"id":3123675,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-06-03T22:26:25.000Z","date":"2020-06-01","kind":"tax_withholding","acquired":false,"shares":66,"price":38.55,"value":2544.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020."}],"balance_after":37681,"source":{"system":"sec-edgar","filing":"0001209191-20-034205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120034205/doc4.xml","form_type":"4"}},{"id":3123674,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-06-03T22:26:25.000Z","date":"2020-06-01","kind":"tax_withholding","acquired":false,"shares":105,"price":38.55,"value":4047.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020."}],"balance_after":37747,"source":{"system":"sec-edgar","filing":"0001209191-20-034205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120034205/doc4.xml","form_type":"4"}},{"id":3138924,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Restricted Stock Units","published_at":"2020-05-21T22:38:14.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":4368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Inogen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month."}],"balance_after":4368,"derivative":{"underlying":"Common Stock","underlying_shares":4368},"source":{"system":"sec-edgar","filing":"0001209191-20-031457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120031457/doc4.xml","form_type":"4"}},{"id":3231663,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-03-04T01:43:45.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":340,"price":45.78,"value":15565.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020."}],"balance_after":37852,"source":{"system":"sec-edgar","filing":"0001209191-20-015817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120015817/doc4.xml","form_type":"4"}},{"id":3231662,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-03-04T01:43:45.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":75,"price":45.78,"value":3433.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020."}],"balance_after":38192,"source":{"system":"sec-edgar","filing":"0001209191-20-015817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120015817/doc4.xml","form_type":"4"}},{"id":3231661,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2020-03-04T01:43:45.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":120,"price":45.78,"value":5493.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020."}],"balance_after":38267,"source":{"system":"sec-edgar","filing":"0001209191-20-015817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120015817/doc4.xml","form_type":"4"}},{"id":3353890,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-12-04T02:43:56.000Z","date":"2019-12-01","kind":"tax_withholding","acquired":false,"shares":66,"price":73.61,"value":4858.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2019."}],"balance_after":38387,"source":{"system":"sec-edgar","filing":"0001209191-19-058927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119058927/doc4.xml","form_type":"4"}},{"id":3353889,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-12-04T02:43:56.000Z","date":"2019-12-01","kind":"tax_withholding","acquired":false,"shares":106,"price":73.61,"value":7802.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2019."}],"balance_after":38453,"source":{"system":"sec-edgar","filing":"0001209191-19-058927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119058927/doc4.xml","form_type":"4"}},{"id":3423060,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-09-05T01:07:40.000Z","date":"2019-09-01","kind":"tax_withholding","acquired":false,"shares":67,"price":46.37,"value":3106.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2019."}],"balance_after":38559,"source":{"system":"sec-edgar","filing":"0001209191-19-048411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119048411/doc4.xml","form_type":"4"}},{"id":3423059,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-09-05T01:07:40.000Z","date":"2019-09-01","kind":"tax_withholding","acquired":false,"shares":107,"price":46.37,"value":4961.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2019."}],"balance_after":38626,"source":{"system":"sec-edgar","filing":"0001209191-19-048411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119048411/doc4.xml","form_type":"4"}},{"id":3502074,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-06-05T01:12:50.000Z","date":"2019-06-01","kind":"tax_withholding","acquired":false,"shares":66,"price":64.47,"value":4255.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2019."}],"balance_after":38733,"source":{"system":"sec-edgar","filing":"0001209191-19-034602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119034602/doc4.xml","form_type":"4"}},{"id":3502073,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-06-05T01:12:50.000Z","date":"2019-06-01","kind":"tax_withholding","acquired":false,"shares":106,"price":64.47,"value":6833.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2019."}],"balance_after":38799,"source":{"system":"sec-edgar","filing":"0001209191-19-034602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119034602/doc4.xml","form_type":"4"}},{"id":3611594,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-03-05T17:19:32.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":185,"price":106.97,"value":19789.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2019."}],"balance_after":38905,"source":{"system":"sec-edgar","filing":"0001209191-19-016173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119016173/doc4.xml","form_type":"4"}},{"id":3611593,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-03-05T17:19:32.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":75,"price":106.97,"value":8022.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2019."}],"balance_after":39090,"source":{"system":"sec-edgar","filing":"0001209191-19-016173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119016173/doc4.xml","form_type":"4"}},{"id":3611592,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-03-05T17:19:32.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":319,"price":106.97,"value":34123.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with the portion of a performance-based restricted stock award that was earned and vested on March 1, 2019."}],"balance_after":39165,"source":{"system":"sec-edgar","filing":"0001209191-19-016173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119016173/doc4.xml","form_type":"4"}},{"id":3611591,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-03-05T17:19:32.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The reported securities represent shares earned and vested on March 1, 2019 based on achievement of the financial performance conditions for the 2018 fiscal year that were approved as part of the 2018 performance-based restricted stock award granted on March 2, 2018."}],"balance_after":39484,"source":{"system":"sec-edgar","filing":"0001209191-19-016173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119016173/doc4.xml","form_type":"4"}},{"id":3611590,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-03-05T17:19:32.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":394,"price":106.97,"value":42146.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with the portion of a performance-based restricted stock award that was earned and vested on March 1, 2019."}],"balance_after":38564,"source":{"system":"sec-edgar","filing":"0001209191-19-016173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119016173/doc4.xml","form_type":"4"}},{"id":3611589,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-03-05T17:19:32.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":1138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities represent shares earned and vested on March 1, 2019 based on achievement of the financial performance conditions for the 2018 fiscal year that were approved as part of the 2017 performance-based restricted stock award granted on August 8, 2017."}],"balance_after":38958,"source":{"system":"sec-edgar","filing":"0001209191-19-016173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119016173/doc4.xml","form_type":"4"}},{"id":3611588,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-03-05T17:19:32.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":2430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares of restricted stock, 25% of which shall vest on March 1, 2020, and 1/16th of which shall vest every three months thereafter on the 1st day of the month, subject in each case to the reporting person remaining a service provider through each such applicable vesting date."}],"balance_after":37820,"source":{"system":"sec-edgar","filing":"0001209191-19-016173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119016173/doc4.xml","form_type":"4"}},{"id":3713019,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-02T23:54:46.000Z","date":"2018-12-31","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012."}],"balance_after":1480,"derivative":{"exercise_price":0.81,"expiration_date":"2022-03-27","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-19-000477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119000477/doc4.xml","form_type":"4"}},{"id":3713018,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2019-01-02T23:54:46.000Z","date":"2018-12-31","kind":"exercise","acquired":true,"shares":14000,"price":0.81,"value":11340.0,"ownership":{"direct":true},"balance_after":35390,"source":{"system":"sec-edgar","filing":"0001209191-19-000477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119000477/doc4.xml","form_type":"4"}},{"id":3745686,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-12-03T22:42:39.000Z","date":"2018-12-01","kind":"tax_withholding","acquired":false,"shares":106,"price":147.36,"value":15620.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2018."}],"balance_after":21390,"source":{"system":"sec-edgar","filing":"0001209191-18-060641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118060641/doc4.xml","form_type":"4"}},{"id":3772516,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-11-07T00:08:32.000Z","date":"2018-10-17","kind":"gift","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21496,"source":{"system":"sec-edgar","filing":"0001209191-18-057468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118057468/doc4.xml","form_type":"4"}},{"id":3825178,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-09-05T20:32:13.000Z","date":"2018-09-01","kind":"tax_withholding","acquired":false,"shares":446,"price":264.91,"value":118149.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2018."}],"balance_after":23496,"source":{"system":"sec-edgar","filing":"0001209191-18-049572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118049572/doc4.xml","form_type":"4"}},{"id":3846101,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"exercise","acquired":false,"shares":877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015."}],"balance_after":14123,"derivative":{"exercise_price":38.54,"expiration_date":"2022-05-15","underlying":"Common Stock","underlying_shares":877},"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846100,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"exercise","acquired":false,"shares":5689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014."}],"balance_after":7102,"derivative":{"exercise_price":16.62,"expiration_date":"2021-03-31","underlying":"Common Stock","underlying_shares":5689},"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846099,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"exercise","acquired":false,"shares":5054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013"}],"balance_after":0,"derivative":{"exercise_price":8.37,"expiration_date":"2023-10-09","underlying":"Common Stock","underlying_shares":5054},"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846098,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":400,"price":231.7175,"value":92687.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average share price of an aggregate total of 400\nshares sold in the price range of $231.53 to $231.84  by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":23942,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846097,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":300,"price":231.1833,"value":69354.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average share price of an aggregate total of 300\nshares sold in the price range of $230.53 to $231.51 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":24342,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846096,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":1769,"price":229.8189,"value":406549.6341,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average share price of an aggregate total of 1,769\nshares sold in the price range of $229.235 to $230.220 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":24642,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846095,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":2050,"price":228.5705,"value":468569.525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average share price of an aggregate total of 2,050\nshares sold in the price range of $228.19 to $229.18 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":26411,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846094,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":5067,"price":227.611,"value":1153304.937,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 5,067\nshares sold in the price range of $227.175 to $228.150 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28461,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846093,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":8699,"price":226.7249,"value":1972279.9051,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 8,699 shares sold in the price range of $226.16 to $227.15 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":33528,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846092,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":6668,"price":225.6624,"value":1504716.8832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 6,668 shares sold in the price range of $225.15 to $226.14 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":42227,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846091,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"exercise","acquired":true,"shares":877,"price":38.54,"value":33799.58,"ownership":{"direct":true},"balance_after":48895,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846090,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"exercise","acquired":true,"shares":5689,"price":16.62,"value":94551.18,"ownership":{"direct":true},"balance_after":48018,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3846089,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-08-14T00:07:19.000Z","date":"2018-08-09","kind":"exercise","acquired":true,"shares":5054,"price":8.37,"value":42301.98,"ownership":{"direct":true},"balance_after":42329,"source":{"system":"sec-edgar","filing":"0001209191-18-046520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118046520/doc4.xml","form_type":"4"}},{"id":3870006,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-11T00:07:20.000Z","date":"2018-07-09","kind":"exercise","acquired":false,"shares":11074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service, sixty percent (60%) of the shares subject to the option vested and became exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010. This option is fully vested as of August 24, 2012."}],"balance_after":0,"derivative":{"exercise_price":0.6,"expiration_date":"2020-02-24","underlying":"Common Stock","underlying_shares":11074},"source":{"system":"sec-edgar","filing":"0001209191-18-042253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118042253/doc4.xml","form_type":"4"}},{"id":3870005,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-07-11T00:07:20.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":11074,"price":200.2188,"value":2217222.9912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 11,074\nshares sold in the price range of $200.00 to $200.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37275,"source":{"system":"sec-edgar","filing":"0001209191-18-042253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118042253/doc4.xml","form_type":"4"}},{"id":3870004,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-07-11T00:07:20.000Z","date":"2018-07-09","kind":"exercise","acquired":true,"shares":11074,"price":0.6,"value":6644.4,"ownership":{"direct":true},"balance_after":48349,"source":{"system":"sec-edgar","filing":"0001209191-18-042253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118042253/doc4.xml","form_type":"4"}},{"id":3885974,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-21T21:22:25.000Z","date":"2018-06-20","kind":"exercise","acquired":false,"shares":8056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person's continued service, sixty percent (60%) of the shares subject to the option vested and became exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010. This option is fully vested as of August 24, 2012."}],"balance_after":11074,"derivative":{"exercise_price":0.6,"expiration_date":"2020-02-24","underlying":"Common Stock","underlying_shares":8056},"source":{"system":"sec-edgar","filing":"0001209191-18-038987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118038987/doc4.xml","form_type":"4"}},{"id":3885973,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-21T21:22:25.000Z","date":"2018-06-20","kind":"sale","acquired":false,"shares":1300,"price":191.5823,"value":249056.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 1,300\nshares sold in the price range of $191.070 to $192.005 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37275,"source":{"system":"sec-edgar","filing":"0001209191-18-038987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118038987/doc4.xml","form_type":"4"}},{"id":3885972,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-21T21:22:25.000Z","date":"2018-06-20","kind":"sale","acquired":false,"shares":6756,"price":190.3822,"value":1286222.1432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 6,756 shares sold in the price range of $190.00 to $190.70 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":38575,"source":{"system":"sec-edgar","filing":"0001209191-18-038987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118038987/doc4.xml","form_type":"4"}},{"id":3885971,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-21T21:22:25.000Z","date":"2018-06-20","kind":"exercise","acquired":true,"shares":8056,"price":0.6,"value":4833.6,"ownership":{"direct":true},"balance_after":45331,"source":{"system":"sec-edgar","filing":"0001209191-18-038987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118038987/doc4.xml","form_type":"4"}},{"id":3888390,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-19T23:19:15.000Z","date":"2018-06-18","kind":"exercise","acquired":false,"shares":1846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continued service, sixty percent (60%) of the shares subject to the option vested and became exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010. This option is fully vested as of August 24, 2012."}],"balance_after":19130,"derivative":{"exercise_price":0.6,"expiration_date":"2020-02-24","underlying":"Common Stock","underlying_shares":1846},"source":{"system":"sec-edgar","filing":"0001209191-18-038685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118038685/doc4.xml","form_type":"4"}},{"id":3888389,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-19T23:19:15.000Z","date":"2018-06-18","kind":"sale","acquired":false,"shares":1846,"price":190.0436,"value":350820.4856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 1,846\nshares sold in the price range of $190.00 to $190.16 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37275,"source":{"system":"sec-edgar","filing":"0001209191-18-038685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118038685/doc4.xml","form_type":"4"}},{"id":3888388,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-19T23:19:15.000Z","date":"2018-06-18","kind":"exercise","acquired":true,"shares":1846,"price":0.6,"value":1107.6,"ownership":{"direct":true},"balance_after":39121,"source":{"system":"sec-edgar","filing":"0001209191-18-038685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118038685/doc4.xml","form_type":"4"}},{"id":3898256,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"exercise","acquired":false,"shares":1171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Subject to the reporting person's continued service, sixty percent (60%) of the shares subject to the option vested and became exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010. This option is fully vested as of August 24, 2012."}],"balance_after":20976,"derivative":{"exercise_price":0.6,"expiration_date":"2020-02-24","underlying":"Common Stock","underlying_shares":1171},"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898255,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":1200,"price":190.4325,"value":228519.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average share price of an aggregate total of 1,200 shares sold in the price range of $190.11 to $190.82 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37275,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898254,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":2000,"price":189.0665,"value":378133.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $188.54 to $189.50 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":38475,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898253,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":1250,"price":187.8117,"value":234764.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average share price of an aggregate total of 1,250 shares sold in the price range of $187.50 to $188.05 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":40475,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898252,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":2141,"price":186.2843,"value":398834.6863,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average share price of an aggregate total of 2,141 shares sold in the price range of $186.00 to $186.84 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":41725,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898251,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":100,"price":184.4925,"value":18449.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."}],"balance_after":43866,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898250,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":2492,"price":183.989,"value":458500.588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 2,492 shares sold in the price range of $183.46 to $184.44 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":43966,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898249,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":816,"price":182.4881,"value":148910.2896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 816 shares sold in the price range of $182.27 to $183.16 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":46458,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898248,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":1171,"price":190.42,"value":222981.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 1,171 shares sold in the price range of $190.05 to $190.82 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":47274,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":3898247,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-06-11T21:36:05.000Z","date":"2018-06-07","kind":"exercise","acquired":true,"shares":1171,"price":0.6,"value":702.6,"ownership":{"direct":true},"balance_after":48445,"source":{"system":"sec-edgar","filing":"0001209191-18-037041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118037041/doc4.xml","form_type":"4"}},{"id":4007997,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-08T01:11:18.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":5798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is January 1, 2008. This option is fully vested as of January 1, 2012."}],"balance_after":0,"derivative":{"exercise_price":2.4,"expiration_date":"2018-03-27","underlying":"Common Stock","underlying_shares":5798},"source":{"system":"sec-edgar","filing":"0001209191-18-017873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118017873/doc4.xml","form_type":"4"}},{"id":4007996,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-03-08T01:11:18.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":5798,"price":2.4,"value":13915.2,"ownership":{"direct":true},"balance_after":47274,"source":{"system":"sec-edgar","filing":"0001209191-18-017873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118017873/doc4.xml","form_type":"4"}},{"id":4010544,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-03-06T22:44:58.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":2131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares of restricted stock, 25% of which shall vest on March 1, 2019, and 1/16th of which shall vest every three months thereafter on the 1st day of the month, subject in each case to the reporting person remaining a service provider through each such applicable vesting date."}],"balance_after":41476,"source":{"system":"sec-edgar","filing":"0001209191-18-017401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118017401/doc4.xml","form_type":"4"}},{"id":4019600,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-03-02T22:52:17.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":393,"price":118.33,"value":46503.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with the portion of the 2017 performance-based restricted stock award that was earned and vested on March 1, 2018."}],"balance_after":39345,"source":{"system":"sec-edgar","filing":"0001209191-18-015937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118015937/doc4.xml","form_type":"4"}},{"id":4019599,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2018-03-02T22:52:17.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":1138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares earned and vested on March 1, 2018 based on achievement of the financial performance conditions for the 2017 fiscal year that were approved as part of the 2017 performance-based restricted stock award granted on August 8, 2017."}],"balance_after":39738,"source":{"system":"sec-edgar","filing":"0001209191-18-015937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118015937/doc4.xml","form_type":"4"}},{"id":4134593,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2017-12-12T23:43:17.000Z","date":"2017-12-11","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Form 3 reported an incorrect expiration date of 03/28/2022."}],"balance_after":15480,"derivative":{"exercise_price":0.81,"expiration_date":"2022-03-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-065267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117065267/doc4.xml","form_type":"4"}},{"id":4134592,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-12-12T23:43:17.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":800,"price":117.945,"value":94356.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 800 shares sold in the price range of $117.72 to $118.54 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":38600,"source":{"system":"sec-edgar","filing":"0001209191-17-065267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117065267/doc4.xml","form_type":"4"}},{"id":4134591,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-12-12T23:43:17.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":5400,"price":117.0654,"value":632153.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 5,400 shares sold in the price range of $116.67 to $117.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":39400,"source":{"system":"sec-edgar","filing":"0001209191-17-065267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117065267/doc4.xml","form_type":"4"}},{"id":4134590,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-12-12T23:43:17.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":3800,"price":116.2192,"value":441632.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 3,800 shares sold in the price range of $115.6350 to $116.6300 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44800,"source":{"system":"sec-edgar","filing":"0001209191-17-065267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117065267/doc4.xml","form_type":"4"}},{"id":4134589,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-12-12T23:43:17.000Z","date":"2017-12-11","kind":"exercise","acquired":true,"shares":10000,"price":0.81,"value":8100.0,"ownership":{"direct":true},"balance_after":48600,"source":{"system":"sec-edgar","filing":"0001209191-17-065267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117065267/doc4.xml","form_type":"4"}},{"id":4154145,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016."}],"balance_after":20000,"derivative":{"exercise_price":44.19,"expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154144,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015."}],"balance_after":15000,"derivative":{"exercise_price":38.54,"expiration_date":"2022-05-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154143,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014."}],"balance_after":12791,"derivative":{"exercise_price":16.62,"expiration_date":"2021-03-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154142,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Previous Form 4 filed on June 5, 2017 reported an incorrect expiration date of 10/10/2023."}],"balance_after":5054,"derivative":{"exercise_price":8.37,"expiration_date":"2023-10-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154141,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"sale","acquired":false,"shares":1850,"price":118.5405,"value":219299.925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 1,850 shares sold in the price range of $118.255 to $119.41 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":38600,"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154140,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"sale","acquired":false,"shares":4330,"price":117.8554,"value":510313.882,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 4,330 shares sold in the price range of $117.16 to $118.14 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":40450,"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154139,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"sale","acquired":false,"shares":28820,"price":116.492,"value":3357299.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 28,820 shares sold in the price range of $116.03 to $117.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44780,"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154138,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"exercise","acquired":true,"shares":5000,"price":44.19,"value":220950.0,"ownership":{"direct":true},"balance_after":73600,"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154137,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"exercise","acquired":true,"shares":10000,"price":38.54,"value":385400.0,"ownership":{"direct":true},"balance_after":68600,"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154136,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"exercise","acquired":true,"shares":10000,"price":16.62,"value":166200.0,"ownership":{"direct":true},"balance_after":58600,"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4154135,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:05:02.000Z","date":"2017-11-17","kind":"exercise","acquired":true,"shares":10000,"price":8.37,"value":83700.0,"ownership":{"direct":true},"balance_after":48600,"source":{"system":"sec-edgar","filing":"0001209191-17-062013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117062013/doc4.xml","form_type":"4"}},{"id":4233808,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-08-15T20:57:50.000Z","date":"2017-08-11","kind":"grant","acquired":true,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares of restricted stock, 25% of which shall vest on September 1, 2018, and 1/16th of which shall vest every three months thereafter on the 1st of the month."}],"balance_after":38600,"source":{"system":"sec-edgar","filing":"0001209191-17-049007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117049007/doc4.xml","form_type":"4"}},{"id":4292654,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-05T19:20:03.000Z","date":"2017-06-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013"}],"balance_after":15054,"derivative":{"exercise_price":8.37,"expiration_date":"2023-10-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-037633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117037633/doc4.xml","form_type":"4"}},{"id":4292653,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-06-05T19:20:03.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":10000,"price":90,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2016."}],"balance_after":35185,"source":{"system":"sec-edgar","filing":"0001209191-17-037633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117037633/doc4.xml","form_type":"4"}},{"id":4292652,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-06-05T19:20:03.000Z","date":"2017-06-02","kind":"exercise","acquired":true,"shares":10000,"price":8.37,"value":83700.0,"ownership":{"direct":true},"balance_after":45185,"source":{"system":"sec-edgar","filing":"0001209191-17-037633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117037633/doc4.xml","form_type":"4"}},{"id":4345471,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Stock Option (right to buy)","published_at":"2017-04-25T23:27:48.000Z","date":"2017-04-24","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014."}],"balance_after":22791,"derivative":{"exercise_price":16.62,"expiration_date":"2021-03-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-028183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117028183/doc4.xml","form_type":"4"}},{"id":4345470,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-04-25T23:27:48.000Z","date":"2017-04-24","kind":"sale","acquired":false,"shares":10000,"price":80,"value":800000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2016."}],"balance_after":35185,"source":{"system":"sec-edgar","filing":"0001209191-17-028183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117028183/doc4.xml","form_type":"4"}},{"id":4345469,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":141264,"kind":"person","name":"Myers Byron","position":1,"cik":"0001596086","reported_name":"Myers Byron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Sales and Marketing"}}],"security":"Common Stock","published_at":"2017-04-25T23:27:48.000Z","date":"2017-04-24","kind":"exercise","acquired":true,"shares":10000,"price":16.62,"value":166200.0,"ownership":{"direct":true},"balance_after":45185,"source":{"system":"sec-edgar","filing":"0001209191-17-028183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919117028183/doc4.xml","form_type":"4"}}],"next_cursor":"2017-04-25T23:27:48.000000Z,4345469"}